Literature DB >> 4033781

Smooth muscle alpha-action is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells.

J Leavitt, P Gunning, L Kedes, R Jariwalla.   

Abstract

Heteroploid mouse NIH 3T3 fibroblasts and several rat fibroblast strains (Rat-1, Rat-2 and REF-52) are cell lines of special interest in the field of carcinogenesis because of their extensive use as normal cells in transformation assays for putative cancer-causing genes. Exposure of these cells to carcinogenic chemicals or oncogenic DNA produces anchorage-independent cells with retracted cytoplasms that lack actin cables. All human fibroblast strains, normal and transformed, synthesize two electrophoretic forms of actin (beta- and gamma-actin). In contrast, we discovered that early-passage mouse and rat strains synthesize abundant amounts of each of the three electrophoretic forms of actin (alpha-, beta- and gamma-actin) but mouse and rat cancer cells express only beta- and gamma-actins. We now show that in NIH 3T3 and Rat-2 fibroblasts a third actin, the smooth muscle alpha isoform, is abundantly co-expressed with beta- and gamma-actin. In every instance tested following transformation to tumorigenicity, the accumulation of alpha-actin messenger RNA and alpha-actin synthesis was greatly inhibited. Shutdown of alpha-actin expression thus appears to be a reproducible transformation-sensitive marker in rodent fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033781     DOI: 10.1038/316840a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.

Authors:  I Kaplan; B T Blakely; G K Pavlath; M Travis; H M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1.

Authors:  O Kocher; J A Madri
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

3.  Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation.

Authors:  R E Gossett; F Schroeder; J M Gunn; A B Kier
Journal:  Lipids       Date:  1997-06       Impact factor: 1.880

4.  Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials.

Authors:  N Blaes; M C Bourdillon; J M Daniel-Lamaziere; J J Michaille; M Andujar; C Covacho
Journal:  In Vitro Cell Dev Biol       Date:  1991-09

5.  Intermediate filament expression and lifespan potential in human somatic cell hybrids.

Authors:  C L Bunn; F A White; W M O'Guin; R H Sawyer; L W Knapp
Journal:  In Vitro Cell Dev Biol       Date:  1985-12

6.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Alterations in the expression of the beta-cytoplasmic and the gamma-smooth muscle actins in hypertrophied urinary bladder smooth muscle.

Authors:  Y S Kim; Z Wang; R M Levin; S Chacko
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

8.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.

Authors:  J Leavitt; S Y Ng; U Aebi; M Varma; G Latter; S Burbeck; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

9.  Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state.

Authors:  J Leavitt; S Y Ng; M Varma; G Latter; S Burbeck; P Gunning; L Kedes
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

10.  Tropomyosin isoform switching in tumorigenic human fibroblasts.

Authors:  J Leavitt; G Latter; L Lutomski; D Goldstein; S Burbeck
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.